Multiple sclerosis drug approved
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
659831
A European study offers more evidence that weekly injections of interferon beta reduce the risk that people with early symptoms of multiple sclerosis will progress to the full-blown disease within two years.
176876
Drugs given to patients with multiple sclerosis can reduce brain tissue loss and slow down the progression of the illness, scientists said on Friday.
521740
A study of cannabis-based drugs shows long-term benefit in easing multiple sclerosis symptoms, scientists say.
265570
Tablets of the drug etravirine were approved Friday by the Food and Drug Administration for the treatment of HIV infection in adults
445553
Drugs given to patients with multiple  sclerosis can reduce brain tissue loss and slow down the  progression of the illness, scientists said on Friday.
205700
Elan shares jumped this morning after it said that US regulators had approved it new once-a-month multiple sclerosis drug. Tysabri, developed by Elan and Biogen and formerly called Antegren, is the first kind
298087
An abundance of vitamin D seems to help prevent multiple sclerosis, according to a study in more than 7 million people that offers some of the strongest evidence yet of the power of the "sunshine vitamin" against MS.
733890
NEW YORK, NOVEMBER 25: The Federal Government has just approved a new medicine for multiple sclerosis that doctors say represents a new treatment approach that will significantly reduce the frequency of disabling episodes.
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
357627
A top compound in development could become an important MS treatment.
189561
US regulators said Tuesday they approved a new cancer drug from Genzyme Corp. for treating a type of childhood leukemia. The Food and Drug Administration, in a statement on its
75340
A gene that helps to stave off the effects of multiple sclerosis has been discovered by scientists.
766094
DUBLIN/NEW YORK  - Patients taking an experimental  multiple sclerosis drug developed by Biogen Idec Inc. BIIB.O  and Elan Corp. ELN.I experienced far fewer relapses in a  clinical trial, data that analysts say could give the drug a  dominant market position.
255760
Biogen Idec Inc., of Cambridge, had a remarkable 2004. Biogen had just finalized its $6.4 billion merger with Idec Corp., of San Diego, when it got word the Food and Drug Administration would consider its new multiple sclerosis drug on the basis of interim trial data, accelerating the approval timetable by a year. The company scrambled, applied on May 25, ...
741309
NEW YORK  - Tylenol (acetaminophen), Motrin  (ibuprofen), and prednisone are equally effective against the  flu-like syndrome that can arise in multiple sclerosis (MS)  patients treated with interferon, new research suggests.
766116
LONDON (CBS.MW) -- Elan (UK:ELA) (ELN) and partner Biogen (BIIB) said the FDA has approved new drug Tysabri to treat relapsing forms of multiple sclerosis.